Bmj Family Highlights

What's new this month in BMJ Journals

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7526.1168 (Published 17 November 2005) Cite this as: BMJ 2005;331:1168
  1. Harvey Marcovitch (h.marcovitch@btinternet.com), BMJ syndication editor

    Plantar fasciitis may respond to botulinum toxin

    An open pilot study in nine patients with chronic plantar fasciitis suggests that botulinum toxin A may prove to be a useful treatment. The patients, whose symptoms had lasted 2-36 (mean 14) months, were given 200 units of the preparation, formulated as Dysport. Pain at rest had diminished substantially at two week follow-up, with the improvement being maintained at one year. No adverse event was encountered. The authors, from Berlin, now intend to conduct a randomised controlled trial.

    Ann Rheum Dis 2005;64: 1659-61


    Embedded Image

    Bupropion not a risk for sudden death

    Analysis of over 9000 patients who had been prescribed the antismoking drug bupropion contradicts claims in the UK tabloid press that the drug may cause sudden death. Data were extracted from a GP database involving 3.1 million patients in 221 practices. Follow-up was …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe